Since its founding in 1886, Johnson & Johnson has been dedicated to addressing major health challenges and promoting a healthier world.
Today, the company released its 2023 Health for Humanity Report, highlighting its progress in environmental, social, and governance (ESG) initiatives.
In 2023, Johnson & Johnson achieved significant milestones in sustainability, global health equity, accountability, and innovation. The company also fostered a work environment where employees are empowered to meet community needs. Here are key takeaways from the report on how Johnson & Johnson is advancing health equity and sustainability.
1. Expanding Access to High-Quality Healthcare
Johnson & Johnson champions global health equity by increasing access to lifesaving treatments and healthcare. In 2023, the company delivered 200 million doses of a drug for treating soil-transmitted helminths, benefiting up to 100 million children and women of reproductive age.
Additionally, Johnson & Johnson and the Johnson & Johnson Foundation supported nearly one million healthcare workers and trained over 40,000 operating room and hospital staff in resource-limited settings.
To address health disparities in the U.S., Johnson & Johnson focuses on enhancing diversity in clinical trials. In 2023, more than 80% of the company’s clinical trials with diversity enrollment goals met their targets.
2. Driving Innovation in Healthcare
Innovation has been central to Johnson & Johnson’s mission since its inception. This commitment earned the company spots on Fortune’s Most Innovative Companies lists.
In 2023, Johnson & Johnson invested $15.1 billion in research and development (R&D) across its Innovative Medicine and MedTech businesses, and $4.9 billion in small and diverse suppliers.
These investments support the creation of cutting-edge products, such as AI algorithms for early disease diagnosis, efficient bladder cancer treatments, and precision medicine approaches in drug development.
3. Enhancing Environmental Health
In 2023, Johnson & Johnson made significant progress in using renewable energy and reducing carbon emissions. The company now sources 100% of its global electricity for operations in Europe, the U.S., and Canada from renewable sources. Since 2021, it achieved a 23% reduction in Scope 1 and Scope 2 greenhouse gas emissions.
Sustainability also involves minimizing product impact on the environment. Johnson & Johnson established a recycling program for single-use medical devices, starting in New Zealand in 2018. By last year, this program had expanded to 11 countries with participating hospitals.
Conclusion
Johnson & Johnson’s 2023 Health for Humanity Report showcases its ongoing efforts to create a healthier, more equitable world through innovation, sustainability, and global health initiatives.
